// company-profile
Traws Pharma, Inc.
TRAWExchangeNasdaqSectorPharmaceutical PreparationsInc.DEFilings65Insiders21
// api This Traws Pharma, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.
// activity-summary
No insider transactions in the last 30 days.
// 90-day insight
Over the last 90 days, Traws Pharma, Inc. insiders bought $998K across 4 transactions with no open-market sales.
- Most active insider: ORBIMED ADVISORS LLC with 4 transactions totaling $998K.
- Largest single purchase: $998K by ORBIMED ADVISORS LLC on Apr 16, 2026.
Activity skews bullish — buys outpace sales.
Institutional Ownership
Top 13F-HR holders of Traws Pharma, Inc. as of 2026-03-31
Total reported AUM
$6.6M
QoQ change
+70.5%
Reporting period
2026-03-31
#1
ADAGE CAPITAL PARTNERS GP, L.L.C.
CIK 1165408
$1.3M
730K shares
#2
Ikarian Capital, LLC
CIK 1778253
$1.2M
678K shares
#3
ORBIMED ADVISORS LLC
CIK 1055951
$1.1M
606K shares
Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Apr 16, 2026 | ORBIMED ADVISORS LLC | TRAW | Purchase | 597,729 | — | — |
| Apr 16, 2026 | ORBIMED ADVISORS LLC | TRAW | Purchase | 597,729 | — | — |
| Apr 16, 2026 | ORBIMED ADVISORS LLC | TRAW | Purchase | 597,729 | $1.67 | $998K |
| Apr 16, 2026 | ORBIMED ADVISORS LLC | TRAW | Purchase | 1,793,187 | — | — |
| Mar 8, 2026 | Dukes Iain D. | TRAW | Award | 231,336 | $0.00 | $0K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Popular companies on Form4API
Browse insider trading activity for other actively-filed companies.